Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Belly fat battle: which body sculpting method lowers inflammation?

NCT ID NCT07307898

Symptom relief Sponsor: Cairo University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study compares two non-invasive body treatments—ultrasound cavitation and whole-body electrical muscle stimulation—to see which better reduces inflammation in people with central obesity (excess belly fat). Sixty adults aged 18-50 with a large waistline will be assigned to one of the treatments. Researchers will measure changes in inflammatory markers and waist size over the study period.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

60 people

The number who actually took part.

Started

Sep 2024

Expected to finish

Jan 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 50 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adults aged 18-50 years. * Individuals diagnosed with central obesity, defined as a waist circumference greater than 102 cm in men and 88 cm in women. * Participants with a stable body weight for at least three months prior to the study. * No engagement in regular physical activity or weight loss programs in the past six months. * Willingness to adhere to study protocols and attend all scheduled sessions. Exclusion Criteria: * Individuals with chronic diseases other than obesity-related conditions, such as cardiovascular disease, diabetes, or severe hypertension. * Pregnant or lactating women. * Individuals with implanted electronic devices (e.g., pacemakers). * Participants with dermatological conditions or skin infections in the treatment area. * Individuals undergoing medication that may affect fat metabolism or inflammatory markers.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Central obesity are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Obesity, Abdominal

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Central obesity

Contacts and locations

Locations

  • Cairo University

    Cairo, Qalyubia Governorate, 13611, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.